© 2001 Journal of Clinical Pathology
Fas ligand upregulation is an early event in colonic carcinogenesis
1 Department of Medicine, University College Cork, Cork, Ireland
2 Department of Surgery, University College Cork
Correspondence to:
Professor Shanahan, Department of Medicine, Clinical Sciences Building, University Hospital, Cork, Ireland Fshanahan{at}ucc.ie
Background/AimsFas ligand (FasL) is a mediator of apoptosis via the Fas receptor (Fas/CD95/APO-1). Normal colonic epithelium expresses Fas, and appears to be relatively sensitive to Fas mediated apoptosis. Colonic adenocarcinomas coexpress FasL and Fas without undergoing widespread apoptosis. This study investigates the expression of FasL in colonic carcinogenesis from the earliest stages of the adenomacarcinoma sequence.
MethodsFasL expression was determined in colonic adenomas (n = 38) of varying degrees of dysplasia and histological type by immunohistochemistry. Adenomas that contained areas of carcinomatous change were included (n = 12 of 38). Normal colonic epithelium (n = 10), hyperplastic polyps (n = 8), and serrated adenomas (n = 3) from patients without colonic adenocarcinomas were used for comparison. Cell death was detected in situ in adenomas using TUNEL (terminal transferase mediated dUTP nick end labelling).
ResultsIn normal colonic epithelium and hyperplastic polyps, FasL expression was restricted to the luminal surface of the crypts, where FasFasL coexpression was coincident with a high frequency of TUNEL positive epithelial cells. All adenomas (n = 38) had an altered distribution of positive FasL staining; FasL expression was found in most cells (> 70% of neoplastic cells). Expression of Fas was also detected throughout the adenomas, but coexpression of FasL and Fas was not associated with TUNEL positivity in most cells.
ConclusionsFasL upregulation occurs early in the adenomacarcinoma sequence of colon carcinogenesis, and is evident at the level of mild dysplasia. The lack of pronounced apoptosis in areas of adenomas coexpressing Fas and FasL suggests that colonocytes acquire resistance to Fas mediated apoptosis early in the transformation process.
Key Words: Fas (CD95/APO-1) Fas ligand colon adenoma
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Liao, W.-T., Yu, C.-L., Lan, C.-C. E., Lee, C.-H., Chang, C.-H., Chang, L. W., You, H.-L., Yu, H.-S.
(2009). Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease. Carcinogenesis
30: 1064-1072
[Abstract] [Full Text] -
Steinmann, C., Landsverk, M. L., Barral, J. M., Boehning, D.
(2008). Requirement of Inositol 1,4,5-Trisphosphate Receptors for Tumor-mediated Lymphocyte Apoptosis. J. Biol. Chem.
283: 13506-13509
[Abstract] [Full Text] -
Nadal, C., Maurel, J., Gallego, R., Castells, A., Longaron, R., Marmol, M., Sanz, S., Molina, R., Martin-Richard, M., Gascon, P.
(2005). FAS/FAS Ligand Ratio: A Marker of Oxaliplatin-Based Intrinsic and Acquired Resistance in Advanced Colorectal Cancer. Clin. Cancer Res.
11: 4770-4774
[Abstract] [Full Text] -
Crowley-Weber, C. L., Payne, C. M., Gleason-Guzman, M., Watts, G. S., Futscher, B., Waltmire, C. N., Crowley, C., Dvorakova, K., Bernstein, C., Craven, M., Garewal, H., Bernstein, H.
(2002). Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis
23: 2063-2080
[Abstract] [Full Text] -
Chen, J. C., Lin, J.-H., Wu, L.-S., Tsai, Y.-F., Su, T. H., Chen, C. J., Chen, T. J.
(2002). Luteotropic Roles of Prolactin in Early Pregnant Hamsters. Biol. Reprod.
67: 8-13
[Abstract] [Full Text] -
Rubio, C A, Jacobsson, B, Bennett, M W, O'Connell, J, Houston, A, Kelly, J, Collins, J K, Shanahan, F, O'Sullivan, G C
(2002). The Fas-FasL system and colorectal tumours. J. Clin. Pathol.
55: 559-559
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
